Heart Disease
Medline Studies
Scientific Studies
Oral EDTA
Competitive Products
Toxic Metals
Main Technical Section For  Chelation Therapy On Line

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Heart Disease & Bypass Surgery Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help

Karl Loren Background

Ingredients
Technical
Write To Karl Loren Table Of Contents

The Lie About Declining Death Rates

Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999  [A Lie!]

Author's Note:  This is one example of the repetition of the complete false data that the death rate from heart disease is declining in the US.  This same claim appeared in thousands of places a few years ago, but when the President of the American Heart Association admitted that the Heart Association was putting out false figures on heart death rates, just to get more government funding, many of these false claims were quietly deleted.  This is how they appeared.  They are regularly now copied and covered as news, even though the original sources have hidden behind fancy words to change the story, such as, "The death rate from heart disease in the US is still one of the highest in the world!"  This implies that it is getting better (?) but has room for improvement.  The fact is that the death rate is INCREASING, and thus the strongly recommended treatments have been proven failures.

Click on the image, just below, for the original source on the web.  See if this article is still published.  These articles have a way of disappearing after I've made them public as lies.


 

August 6, 1999 / 48(30);649-656

Achievements in Public Health, 1900-1999: Decline in Deaths from Heart Disease and Stroke -- United States, 1900-1999

Top

Heart disease has been the leading cause of death in the United States since 1921, and stroke has been the third leading cause since 1938 (1); together they account for approximately 40% of all deaths. Since 1950, age-adjusted death rates from cardiovascular disease (CVD) have declined 60%, representing one of the most important public health achievements of the 20th century. This report summarizes the temporal trends in CVD, advances in the understanding of risk factors for CVD, development of prevention interventions to reduce these risks, and improvements in therapy for persons who develop CVD.

Decline in CVD Death Rates

Age-adjusted death rates per 100,000 persons (standardized to the 1940 U.S. population) for diseases of the heart (i.e., coronary heart disease, hypertensive heart disease, and rheumatic heart disease) have decreased from a peak of 307.4 in 1950 to 134.6 in 1996, an overall decline of 56% (1) (Figure 1). Age-adjusted death rates for coronary heart disease (the major form of CVD contributing to mortality) continued to increase into the 1960s, then declined. In 1996, 621,000 fewer deaths occurred from coronary heart disease than would have been expected had the rate remained at its 1963 peak (1).

Age-adjusted death rates for stroke have declined steadily since the beginning of the century. Since 1950, stroke rates have declined 70%, from 88.8 in 1950 to 26.5 in 1996. Total age-adjusted CVD death rates have declined 60% since 1950 and accounted for approximately 73% of the decline in all causes of deaths during the same period (1).

Disease Epidemiology

Intensive investigation into the CVD epidemic largely began in the 1940s following World War II, although causal hypotheses about CVD and recognition of geographic differences in disease rates occurred earlier (2-4). Landmark epidemiologic investigations, including the cross-country comparisons of Ancel Keys (5) (see box) and the Framingham Heart Study (6), established the major risk factors of high blood cholesterol, high blood pressure, and smoking and dietary factors (particularly dietary cholesterol, fat, and sodium). The risk factor concept--that particular biologic, lifestyle, and social conditions were associated with increased risk for disease--developed out of CVD epidemiology (3,4). In addition to the major risk factors (i.e., high blood pressure, high blood cholesterol, and smoking), other important factors include socioeconomic status, obesity, and physical inactivity (7). Striking regional differences were noted particularly for stroke mortality, with the highest rates observed in the southeastern United States (1). Cross-national and cross-cultural studies highlighted the importance of social, cultural, and environmental factors in the development of CVD.

Coronary heart disease and stroke, the two major causes of CVD-related mortality, are not influenced to the same degree by the recognized risk factors. For example, elevated blood cholesterol is a major risk factor for coronary heart disease, and hypertension is the major risk factor for stroke. Physical activity, smoking cessation, and a healthy diet, which can lower the risk for heart disease, also can help lower the risk for stroke (8).

Advances in Prevention

Early intervention studies in the 1960s sought to establish whether lowering risk factor levels would reduce risk for CVD (2-4). During the 1970s and 1980s, along with numerous clinical trials demonstrating the efficacy of antihypertensive and lipid-lowering drugs, community trials sought to reduce risk at the community level (9). Public health interventions to reduce CVD have benefitted from a combination of the "high risk" approach--aimed at persons with increased risk for CVD--and the population-wide approach--aimed at lowering risk for the entire community (10). National programs that combine these complementary approaches and that are aimed at health-care providers, patients, and the general public include the National High Blood Pressure Education Program (11), initiated in 1972, and the National Cholesterol Education Program, initiated in 1985 (12). Although earlier CDC community demonstration projects focused on cardiovascular health (9), CDC established its National Center for Chronic Disease Prevention and Health Promotion in 1989, with a high priority of promoting cardiovascular health.

Factors Contributing to the Decline in CVD Deaths

Reasons for the declines in heart disease and stroke may vary by period and across region or socioeconomic groups (e.g., age, sex, and racial/ethnic groups). Prevention efforts and improvements in early detection, treatment, and care have resulted in a number of beneficial trends (Table 1), which may have contributed to declines in heart disease and stroke. These trends include

Challenges for the 21st Century

Despite remarkable progress, heart disease and stroke remain leading causes of disability and death. Estimated costs for morbidity and mortality from CVD, including health expenditures and lost productivity, are expected to be $286.5 billion in 1999 (18). In addition, the overall declines in heart disease and stroke mortality mask important differences in rates of decline by race/ethnicity, sex, socioeconomic status, and geographic region. During 1985-1996, for example, heart disease age-adjusted mortality declined 29% among white men, but only 10% among American Indian/ Alaskan Native women (13). Persons of lower socioeconomic status have higher mortality, morbidity, and risk factor levels for heart disease and stroke than persons of higher socioeconomic status (13,19). In addition, the social class gap in heart disease deaths may be increasing as the rates of heart disease decline faster among higher social classes (19). Geographically, declines in heart disease deaths did not occur at the same time for all communities. Areas with poorer socioeconomic profiles were more likely to experience a later onset of the decline of heart disease (19).

Public health programs at the state level for heart disease and stroke have been limited. In fiscal year 1999, through a new program, CDC funded 11 states with the highest CVD mortality rates to plan, develop, and implement state-based efforts for CVD prevention. In addition to activities such as surveillance, these programs will emphasize policy and environmental interventions, both social and physical, aimed at sustaining positive health behavior change.

Although many trends have been positive, trends for some important indicators have not improved substantially, have leveled off, or are reversing. For example, approximately 70% of persons with hypertension do not have the condition controlled at levels below 140/90 mm Hg, and death rates for stroke have not declined in recent years (1,11,13). Heart failure has emerged as a health concern for older adults (20), and adults who survive a myocardial infarction or other hypertension-related diseases remain at increased risk for heart failure. In addition, the prevalence of obesity has increased among both children and adults in the United States (13).

Major public health challenges for the 21st century include

Reported by: Cardiovascular Health Br, Div of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.

References

  1. National Heart, Lung and Blood Institute. Morbidity & mortality: 1998 chartbook on cardiovascular, lung, and blood diseases. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, 1998.
  2. Epstein FH. Contribution of epidemiology to understanding coronary heart disease. In: Marmot M, Elliott P, eds. Coronary heart disease epidemiology: from aetiology to public health. New York: Oxford University Press, 1992:20-32.
  3. Epstein FH. Cardiovascular disease epidemiology: a journey from the past into the future. Circulation 1996;93:1755-64.
  4. Stamler J. Established major coronary risk factors. In: Marmot M, Elliott P, eds. Coronary heart disease epidemiology: from aetiology to public health. New York: Oxford University Press, 1992:35-66.
  5. Keys A. Seven countries--a multivariate analysis of death and coronary heart disease. Cambridge, Massachusetts: Harvard University Press, 1980.
  6. Dawber TR. The Framingham study: the epidemiology of atherosclerotic disease. Cambridge, Massachusetts: Harvard University Press, 1980.
  7. National Heart, Lung and Blood Institute. Report of the task force on research in epidemiology and prevention of cardiovascular diseases. Rockville, Maryland: National Institutes of Health, 1994.
  8. Labarthe DR. Epidemiology and prevention of cardiovascular diseases: a global challenge. Gaithersburg, Maryland: Aspen, 1998.
  9. CDC/Stanford University School of Medicine. Worldwide efforts to improve heart health: a follow-up of the Catalonia Declaration--selected program descriptions. Atlanta: US Department of Health and Human Services, CDC, 1997.
  10. Rose G. The strategy of preventive medicine. New York: Oxford University Press, 1992.
  11. National Institutes of Health. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, November 1997. (NIH publication no. 98-4080).
  12. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, 1993. (NIH publication no. 93-3095).
  13. National Center for Health Statistics. Health, United States, 1998 with socioeconomic status and health chartbook. Hyattsville, Maryland: US Department of Health and Human Services, CDC, 1998.
  14. National Center for Health Statistics. Healthy people 2000 review, 1997. Hyattsville, Maryland: US Department of Health and Human Services, CDC, 1997.
  15. Gerrior S, Bente L. Nutrient content of the U.S. food supply, 1909-94. Washington, DC: US Department of Agriculture, 1997. (Home economics research report no. 53).
  16. Ernst ND, Sempos ST, Briefel RR, Clark MB. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination surveys. Am J Clin Nutr 1997;66:965S-972S.
  17. Higgins M, Thom T. Trends in CHD in the United States. Int J Epidemiol 1989;18:S58-S66.
  18. American Heart Association. 1999 Heart and stroke statistical update. Dallas, Texas: American Heart Association, 1998.
  19. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973-98.
  20. CDC. Changes in mortality from heart failure--United States, 1980-1995. MMWR 1998; 47:633-7.



Table 1



Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size.


TABLE 1. Estimated change in risk factors and correlates for heart disease and stroke, by selected characteristics -- United
States
===================================================================================================================================
Characteristic                                            Baseline year   Baseline estimate   Follow-up year  Follow-up estimate
--------------------------------------------------------------------------------------------------------------------------------
Adults aged 20-74 years with hypertension*+                   1960-1962           37%            1988-1994            23%
Persons with hypertension who are taking action to
  control their blood pressure (e.g., medication, diet,
  reducing salt intake, and exercise)                              1985           79%                 1990            90%
Persons with hypertension whose blood pressure is
  controlled                                                  1976-1980           11%            1988-1991            29%
Adults aged 20-74 years with high blood cholesterol+&         1960-1962           32%            1988-1994            19%
Mean serum cholesterol levels mg/dL of adults
  aged >=18 years+                                            1960-1962           220            1988-1994            203
Adults aged >=18 years who are current smokers+                    1965           42%                 1995            25%
Persons who are overweight+@                                  1960-1962           24%            1988-1994            35%
Percentage of calories in the diet from fat**                 1976-1980           36%            1988-1994            34%
Percentage of calories in the diet from saturated fat**       1976-1980           13%            1988-1994            12%
Number of physicians indicating cardiovascular
  diseases as their primary area of practice                       1975         5,046                 1996         14,304
--------------------------------------------------------------------------------------------------------------------------------
 * Systolic pressure >=140 mm Hg, diastolic pressure >=90 mm Hg, or taking antihypertensive medication.
 + Estimate is age-adjusted to the 1940 U.S. population.
 & Serum cholesterol level >=240 mg/dL (6.2 mmol/L).
 @ Defined as a body mass index >=27.8 kg/m² among men and 27.2 kg/m² among women.
** Based on 1-day dietary recall.
Source: References 11-14.
===================================================================================================================================

[Karl Loren:  Remember, the graph below is a complete lie!  It is hard to believe, but true, that a lie of such magnitude could be accomplished without anyone knowing about it.  You find it HERE, but not elsewhere on the web!]


Return to top.
Figure 1


Return to top.

If you missed it, you can go to either a SHORT explanation of the whole story, or a detailed explanation on ONE PAGE.  On this page you are getting more detail on one part of the story, but on either of those pages you can get the broad picture.  Don't miss reading one of them.  You can actually spend many hours on this web site, depending on the depth of research and reading you want to do.  There are an amazing 4,000 pages here -- more information on these general subjects than almost all other web sites combined!  At some point along the way you will probably say, "Karl's crazy," and leave never to return to this site, or you will say "I want to try some of that oral chelation formula he writes about!"

 



Special Pages On The Various of 12 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.